BioCentury
ARTICLE | Company News

Oculus, Quinnova Pharmaceuticals Inc. sales and marketing update

February 21, 2011 8:00 AM UTC

Oculus granted Quinnova U.S. and Canadian rights to Epicyn Hydrogel for $500,000. The shelf-stable hypochlorous acid formulation that uses Oculus' Microcyn technology received FDA clearance earlier ...